XYou may have noticed, we have just launched our new website. We will be adding more features over the upcoming weeks that you will like, so there may be a few hiccups along the way. If this is your first time visiting since our relaunch, please reset your password so you can still access our journals and CME activities that we have been providing for over 80 years. If you have any questions or comments please contact us at webadmin@psychiatrist.com.
XYou may have noticed, we have just launched our new website. We will be adding more features over the upcoming weeks that you will like, so there may be a few hiccups along the way. If this is your first time visiting since our relaunch, please reset your password so you can still access our journals and CME activities that we have been providing for over 80 years. If you have any questions or comments please contact us at webadmin@psychiatrist.com.
Does suicide risk shortly after discharge from psychiatric hospitalization differ from risk thereafter? This study compared risk factors for suicide in US veterans in the first 90 days after discharge to those during the remainder of the year.
Understanding risk factors for suicidal behavior is crucial for the development of effective prevention plans. Do anxiety disorders or alcohol use disorder play a role? Learn more in this CME activity.
In this commentary, the author describes factors associated with suicide among doctors during the COVID-19 pandemic and provides possible interventions.
Sociodemographic factors, health behaviors, and biological indicators as risks for suicide are relatively understudied among young adults. This study sought to determine which nonpsychiatric factors might be associated with suicide among young people.
The COVID-19 pandemic presents challenges with regard to suicide prevention in the elderly. The authors of this article provide recommendations for interview strategies in this population using 3 sucide theories.
Is hopelessness a critical risk factor for suicidal intent, especially for depressed individuals? The authors of this brief report explore the link between hopelessness and suicidal intent and offer suggestions for future research.
This study compared the prevalence of depression and suicidal behavior along with the use and cost of related treatment in young adults with and without attention-deficit/hyperactivity disorder using commercial claims data.
Suicide rates are an indicator used to monitor mental health in the UN's Sustainable Development Goals. This study analyzed WHO and UN data from 62 countries to see if suicide rates and happiness are correlated. Read it to see the surprising results.
Baclofen, a French Exception, Seriously Harms Alcohol Use Disorder Patients Without Benefit
To the Editor: Dr Andrade’s analysis of the Bacloville trial in a recent Clinical and Practical Psychopharmacology column, in which he concluded that “individualized treatment with high-dose baclofen (30-300 mg/d) may be a useful second-line approach in heavy drinkers” and that “baclofen may be particularly useful in patients with liver disease,” deserves comment.1
First, Andrade failed to recall that the first pivotal trial of baclofen, ALPADIR (NCT01738282; 320 patients, as with Bacloville), was negative (see Braillon et al2).
Second, Dr Andrade should have warned readers that Bacloville’s results are most questionable, lacking robustness. Although he cited us,3 he overlooked the evidence we provided indicating that the Bacloville article4 was published without acknowledging major changes to the initial protocol, affecting the primary outcome. Coincidentally (although as skeptics, we do not believe in coincidence), the initial statistical team was changed when data were sold to the French pharmaceutical company applying for the marketing authorization in France. As Ronald H. Coase warned, “If you torture the data long enough, it will confess.”